The National Institute of Health and Care Excellence (NICE) has published new guidance for the month of November 2014. This month there is one clinical guideline, one technology appraisal and one public health guideline that impacts upon primary care.
The Obesity clinical guideline updates and replaces section 1.2 of NICE clinical guideline 43. It offers evidence-based advice on the care and treatment of obesity and includes new recommendations about low-calorie and very-low-calorie diets, bariatric surgery and follow-up care.
New recommendations have been added about low-calorie and very-low-calorie diets, bariatric surgery and follow-up care.
The Nalmefene for reducing alcohol consumption technology appraisal recommends this drug a possible treatment for people with alcohol dependence who:
- are still drinking more than 7.5 units per day (for men) and more than 5 units per day (for women) 2 weeks after an initial assessment and
- do not have physical withdrawal symptoms and
- do not need to either stop drinking straight away or stop drinking completely
The guidance also recommends that nalmefene should only be taken if the person is also having ongoing support to change their behaviour and to continue to take their treatment, to help them reduce their alcohol intake.
The Vitamin D: increasing supplement use among at-risk groups public health guideline aims to increase supplement use to prevent vitamin D deficiency among at-risk groups including:
- infants and children aged under 5
- pregnant and breastfeeding women, particularly teenagers and young women
- people over 65
- people who have low or no exposure to the sun, for example, those who cover their skin for cultural reasons, who are housebound or confined indoors for long periods
- people with darker skin, for example, people of African, African-Caribbean or South Asian family origin
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
Updated: 27/11/2014 to include "Obesity: identification, assessment and management of overweight and obesity in children, young people and adults" Clinical Guideline
|« Drug Safety Update - November 2014||SMC Update - December 2014 »|